Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are anticipating strong performance driven by the continued success of Lilly's blockbuster medications, particularly its insulin portfolio. However, there are also concerns about potential he